Objective: To report a series of 11 patients on the severe end of the spectrum of ryanodine receptor 1 (RYR1) gene-related myopathy, in order to expand the clinical, histologic, and genetic heterogeneity associated with this group of patients.
Central core disease (CCD) is a form of congenital myopathy due mostly to dominant, and occasionally to recessive, mutations in the skeletal muscle ryanodine receptor 1 (RYR1) gene, characterized clinically by a static to slowly progressive course beginning with congenital hypotonia. 1-3 RYR1 is a 106 exon gene that encodes the skeletal muscle ryanodine receptor, an intracellular calcium-release channel that is crucial to excitation-contraction coupling in muscle. 1, [4] [5] [6] Patients with classic CCD typically present in infancy or early childhood with mild to moderate hypotonia, motor-development delay, proximal muscle weakness, and occasionally with congenital hip dislocation. 1, 4 A subset of patients with RYR1-associated myopathy have a more severe or even lethal neonatal form of the disorder, with features such as decreased fetal movement, polyhydramnios, arthrogryposis, kyphoscoliosis, or respiratory distress. 1, 4, [7] [8] [9] Typical histologic findings on muscle biopsy include well-defined cores of varying size, centrally or peripherally located, or uneven areas of clearing with oxidative enzyme stains due to absence or low number of mitochondria in those regions. 1 Other reported histologic findings include type 1 fiber predominance and fibertype disproportion, multi-minicores, and centrally placed nuclei. 1, [10] [11] [12] The degree of pathologic changes may vary based on sampling site and age of the patient; very young cases in particular may not show clear-cut cores, suggesting an age-related development of the cores. 1, 2, 13 Herein, we present a series of patients with a severe neonatal RYR1-associated myopathy caused by both dominant and recessive mutations of the RYR1 gene to broaden the known clinicopathologic spectrum in this disorder.
METHODS Clinical. Eleven patients with confirmed RYR1
mutations and neonatal or infantile onset of disease were included; 10 were seen at the Children's Hospital of Philadelphia from 2003 to present and 1 patient was identified on remote consultation and review of his biopsy.
Standard protocol approvals, registrations, and patient consents. This study was reviewed by the local institutional review board and was determined not to involve human subjects research and therefore did not require further approval. Written consent to disclose for recognizable persons in photographs was obtained from patients' parents or guardians.
Genetic analysis. Full gene sequencing of RYR1 was performed at Prevention Genetics laboratory in Marshfield, WI for patients 1-5 and 11; partial gene analysis of N-and C-terminal exons was done in patient 7. UCH, Grenoble, France performed testing in patients 8 and 9 by full sequencing of cDNA transcript from muscle, and in patients 6 and 10 by targeted analysis of N-and C-terminal exons.
Muscle imaging. Muscle ultrasound was performed in 6 patients on a Sonoline Adara or Acuson S2000 machine (Siemens, Erlangen, Germany) using linear array transducers VFX13-5 at 12 MHz or 18L6 HD at 15 MHz, respectively, operated by an experienced clinician (C.G.B.).
Pathology. Muscle biopsy was performed in all 11 patients at ages ranging from 3 weeks to 4 years. Patient 11 had a repeat biopsy at age 16 years. Muscle biopsies were snap-frozen in isopentane cooled in liquid N 2 . Routine stains included hematoxylin & eosin, modified Gömöri trichrome, picrosirius, Oil Red O, periodic acid-Schiff, alkaline phosphatase, acid phosphatase, Abbreviations: AD 5 autosomal dominant; AR 5 autosomal recessive; MH 5 malignant hyperthermia. a Leu574 is fully conserved through zebrafish; PolyPhen score: 0.999. b Phe41 is highly conserved; PolyPhen score: 1.000. c Of note, the mother for patients 8 and 9 was found to have a very low amount of c.4581T nucleotide allele in addition to the wild-type c.14581C allele on the sequencing chromatogram. A somatic mosaicism is thus likely to be present in the mother and responsible for the recurrence of the disease in the children. d Presumed de novo, testing in mother was negative, testing not performed in the clinically unaffected father. e Parental testing not performed.
adenosine triphosphatase at pH 9.4 and 4.3, nicotinamide adenine dinucleotide dehydrogenase (NADH)-tetrazolium reductase (TR), succinic dehydrogenase (SDH), cytochrome oxidase (COX), and combined COX/SDH. 14 Immunohistochemistry for fast and slow myosin was performed in 7 cases and for developmental, neonatal myosin and neural cell adhesion molecule (N-CAM) in 7 cases (patients 1, 3, 4, 6, 7, 10, and 11).
RESULTS Clinical presentation. Nine unrelated patients and 1 pair of siblings from nonconsanguineous families were included, all presenting with symptoms in the neonatal period. Nine had symptoms noted in utero, including decreased perceived fetal movements, polyhydramnios, and intrauterine growth restriction (table 1) .
Features present at birth (figure 1) included hypotonia (n 5 11), feeding difficulties (n 5 8), arthrogryposis manifesting as adducted thumb (figure 1, E and F), finger flexor contractures, foot contractures (n 5 6), and other orthopedic complications such as hip dislocations or long-bone fractures (n 5 4). Congenital or early-onset kyphoscoliosis and early rapid progression of scoliosis was seen in 5 patients (figure 1, G-I). Respiratory function was moderately to severely impaired in 5 patients, ranging from mild hypoxia at birth to an inability to wean from the ventilator (figure 1B). One patient died at 24 days of life after withdrawal of support because of inability to wean, and 1 patient died at 4 years of age. Of the living patients, 1 remains on ventilatory support at the age of 5 years, 6 months. The remaining patients range in current age from 2 years, 4 months to 22 years. Only patient 1 has a mildly affected parent, which was detected in the setting of the evaluation of the much more affected child. Creatine kinase levels were all within normal range. Noteworthy neonatal findings included a cleft palate in patient 1 (figure 1D), congenital rigid spine in patient 10, and near complete ophthalmoparesis in patients 4, 5, and 11.
All patients had delayed motor milestones. Only 2 patients achieved independent ambulation. There was no evidence of intellectual impairment in any of the patients. Patient 11, the oldest patient in this cohort, never achieved the ability to ambulate, but retains the ability to sit independently.
Genetic analysis. Dominantly acting mutations were determined in 4 patients. Six patients were compound heterozygous for RYR1 gene mutations (table 1) , including compound heterozygosity for a null allele and a missense mutation (patients 1, 3, and 4), for an in-frame deletion and a missense mutation (patients 5 and 6), for 2 missense changes (patient 2), and for 3 mutations: a previously reported missense mutation and splice-site mutation, plus a novel splice-site mutation (patient 11). Patient 1 had 1 maternally inherited missense change and a de novo frameshift mutation on the other allele. The mother was affected by minimal proximal weakness, but had ultrasound findings compatible with RYR1-associated myopathy (i.e., myopathic changes in the quadriceps with relative sparing of the rectus femoris).
Muscle imaging. In the 6 patients with muscle ultrasound, a consistent finding of relative sparing of involvement of the rectus femoris muscle in comparison to the other components of the quadriceps was seen (patients 1, 2, 3, 4, 7, and 10; figure 1K ). Patients 1, 4, and 10 showed equal involvement of the tibialis anterior, gastrocnemius, and soleus, whereas patient 2 showed striking involvement of the gastrocnemius muscle with relative sparing of the soleus and tibialis anterior. Imaging in the upper extremities demonstrated more variability without uniform features. In patients 2 and 10, paraspinal muscles were also affected. No fasciculations were seen in any patients.
Pathology. Classic cores on NADH-TR, SDH, and COX stains were seen in the majority of dominant cases (patients 7, 8, and 10), but in only 1 of the recessive cases (patient 6, figure 2B ). Multi-minicores were seen in patient 9. The recessive cases had extremely diverse pathology (figures 2 and 3; table e-1 on the Neurology ® Web site at www.neurology.org). Patient 3 was dominated by fibrosis, adipose tissue infiltration, strikingly small size of fibers, and occasional fibers with ill-defined cores on NADH-TR staining (figure 3, E and F). Very small fibers were also seen in patients 2 and 6. The very small fibers were predominantly fast fibers, and were largely positive for neonatal and developmental myosin, and less so for N-CAM (table e-1, figure e-1).
Patients 2 and 11 appeared reminiscent of a dystrophic myopathy, except for the absence of prominent degenerating and clearly regenerating fibers ( figure 3C ). Fibers in patient 4 exhibited frequent internally placed nuclei with irregularities on NADH, including illdefined cores and unevenness of stain ( figure 3, A and  B) . Patients 1 and 5 demonstrated only mild fibrosis, and nonspecific myopathic changes without cores were seen with oxidative enzyme stains (figure 2, C-F). A striking predominance of type 1 staining fibers with the associated properties of slow fibers was seen in patients 1, 3, 4, 6, 7, 10, and 11 in both dominant and recessive cases (not shown). If cores were not seen with oxidative enzyme stains, there was also no evidence of core equivalents on electron microscopy. DISCUSSION With the availability of complete genetic analysis of the RYR1 gene, the phenotypic spectrum of RYR1-related myopathy is evolving to include patients with a more severe neonatal onset. 8, 12 Our series expands the striking heterogeneity in clinical, genetic, and histologic features at the severe end of RYR1-associated myopathy. Histologically, compared with the dominant cases, the recessive cases showed the greatest histopathologic variability to include findings suggestive of RYR1-associated myopathy such as central cores, multi-minicores, 15 or more subtle unevenness of stains, but also central nuclei, extensive fatty and connective tissue infiltration in the absence of prominent degeneration, and regeneration. Marked type 1 fiber predominance approaching type 1 uniformity was common. The occurrence of extremely small fibers was striking in 3 of our recessive cases. The small fibers are conspicuous for their expression of neonatal and developmental myosin. These small fibers are unlikely regenerating fibers following a necrotic or degenerating process, as there was little evidence for muscle fiber degeneration as a trigger for regeneration. Rather, this type of expression may reflect persistence or recapitulation of a developmental program, but it is not possible to determine with certainty whether the fibers represent a primary growth retardation or secondary atrophy. It is possible that the extremely small fibers lack individual neuromuscular junctions, leading to expression of N-CAM. Clinical severity may not correlate with the degree of histologic change. One very severe patient with complete ophthalmoplegia and respiratory insufficiency from birth had a largely nonspecific myopathic-appearing biopsy with very occasional fibers with centrally placed nuclei and no irregularities on the oxidative enzyme stains (patient 5). Thus, the absence of cores should not preclude consideration of an RYR1-associated myopathy, as age at biopsy and site of biopsy may influence the detection of classic cores. We find that the degree of clinical variability in patients with a neonatal-onset RYR1-associated myopathy appears to be even greater than previously described. Findings such as decreased fetal movement, polyhydramnios, hypotonia, arthrogryposis, respiratory insufficiency, and feeding difficulties were seen in nearly all patients in this series, and are consistent with previously reported cases of the severe neonatal phenotype. 9, 16 Patient 10 with a de novo dominant mutation had clinically impressive spinal rigidity of neonatal onset. In addition, early-onset kyphoscoliosis as well as a rapid and early progression of scoliosis was seen in 4 patients, 1 of whom demonstrated paraspinal muscle involvement on muscle ultrasound. Cleft palate as seen in patient 1 has also not previously been described in patients with RYR1 mutations, but has been reported in the context of other severe congenital disorders of muscle. 17 Ophthalmoplegia in association with RYR1 myopathy has been associated with histologic findings of centronuclear or multi-minicore myopathy 12, 15, [18] [19] [20] ; it was present in 3 of the 7 patients with recessive RYR1 mutations including in patient 5 without these typical histologic findings. Notably, not all severe recessive patients in our series had ophthalmoplegia. Despite this great clinical variability, we find the consistent sparing of the rectus femoris on muscle ultrasound imaging a very useful clinical sign to suggest an RYR1-related myopathy as a possibility.
The molecular mechanisms by which dominant vs recessive mutations lead to ryanodine receptor dysfunction and myopathy are not completely clear. Dominant mutations associated with CCD are clustered in the C-terminal portion of RYR1 and likely result in functional abnormalities of the intracellular calcium-release channel. 5 In contrast, a clear clustering of recessive RYR1 mutations is not yet clearly apparent. Recessive patients were typically compound heterozygous for a null allele in conjunction with a missense mutation or 2 frame-preserving mutations (missense mutations and/or in-frame deletions). Some but not all of these missense mutations are in the N-terminal portion of the RYR1 gene classically thought to be associated with the malignant hyperthermia phenotype, with obvious implications for counseling of clinically unaffected family members carrying the potential malignant hyperthermia predisposition allele. Interestingly, patient 1 was a compound heterozygote for a frameshifting c.2038delC deletion and a maternally inherited missense p.Leu574Val change. The carrier mother was mildly affected, suggesting that p.Leu574Val acts in a dominant fashion on its own, but occurring in conjunction with the second pathogenic allele would lead to a much more severe phenotype as observed in patient 1. Of interest among the dominant mutations were patients 8 and 9 (siblings) who inherited the mutation from their mother who was found to have a low degree of somatic mosaicism. 16, [21] [22] [23] [24] With the rising awareness of the multifaceted clinical and histologic spectrum of RYR1-associated myopathy and the more common access to full molecular genetic analysis of the gene, the RYR1 spectrum will likely expand even further. 
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